Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
Rx Propellant, science and R&D infrastructure platform established by Actis, gr...
Excipients are becoming a strategic lever in India’s move toward high-value, gl...
AI is reshaping pharma commercialisation, transforming how companies engage hea...
Under the agreement, Biocodex will hold an exclusive worldwide licence to develo...
The companies plan to jointly develop at least two research and development (R&D...
Nandakumar Kalathil, Country General Manager – India, Agilent Technologies, sha...
Exclusive partnership with Hikma Pharmaceuticals to commercialise product acros...
The FDA accepted the gene therapy’s application under the accelerated approval p...
The Takeda-Iambic AI drug discovery collaboration will initially focus on projec...
Collaboration to evaluate AI-led discovery across antibodies, ADCs and gene the...
Platform to coordinate development, manufacturing and supply of SPCs for cardio...
Inspection concluded with no Form 483 observations, company informs stock exch...
Approval covers import and marketing of Imfinzi for use with chemotherapy in fi...
ACG Packaging Materials reports second Lighthouse recognition under WEF framew...
The partnership represents the seventh agreement between the two companies and a...
New entity to deliver customised engineering and automation solutions The post ...
